[1]宋志刚,魏少华.577 nm激光光凝联合玻璃体内注射康柏西普治疗糖尿病性黄斑水肿的效果观察[J].眼科新进展,2019,39(4):373-375.[doi:10.13389/j.cnki.rao.2019.0085]
 SONG Zhi-Gang,WEI Shao-Hua.Effect of 577 nm laser photocoagulation combined with intravitreal injection of conbercept on diabetic macular edema[J].Recent Advances in Ophthalmology,2019,39(4):373-375.[doi:10.13389/j.cnki.rao.2019.0085]
点击复制

577 nm激光光凝联合玻璃体内注射康柏西普治疗糖尿病性黄斑水肿的效果观察/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
39卷
期数:
2019年4期
页码:
373-375
栏目:
应用研究
出版日期:
2019-04-05

文章信息/Info

Title:
Effect of 577 nm laser photocoagulation combined with intravitreal injection of conbercept on diabetic macular edema
作者:
宋志刚魏少华
457000 河南省濮阳市,濮阳市第二人民医院眼底内科
Author(s):
SONG Zhi-GangWEI Shao-Hua
Department of Ophthalmology,Puyang Second People’s Hospital,Puyang 457000,Henan Province,China
关键词:
577 nm激光康柏西普糖尿病性黄斑水肿
Keywords:
577 nm laserconberceptdiabetic macular edema
分类号:
R774.5
DOI:
10.13389/j.cnki.rao.2019.0085
文献标志码:
A
摘要:
目的 探讨577 nm激光光凝联合玻璃体内注射康柏西普治疗糖尿病性黄斑水肿的效果。方法 选取2016年1月至2017年3月在我院治疗的糖尿病性黄斑水肿患者81例81眼,根据患者最终选取的治疗方案分为观察组43例43眼和对照组38例38眼,观察组给予577 nm激光光凝联合玻璃体内注射康柏西普治疗,对照组仅给予577 nm激光光凝,观察两组治疗前后最佳矫正视力(best corrected visual acuity,BCVA)和黄斑中心凹厚度(central fovea of macula thickness,CMT),分析观察组BCVA和CMT变化值与初始因素的相关性。结果 随治疗时间延长,观察组和对照组BCVA、CMT相应改善(均为P<0.05);观察组治疗后1个月、3个月和6个月BCVA分别为0.37±0.09、0.44±0.10和0.52±0.13,均明显高于对照组(均为P<0.05);观察组治疗后1个月、3个月和6个月CMT分别为(351.03±41.43)μm、(270.32±40.03)μm和(220.01±32.91)μm,均明显低于对照组(均为P<0.05);BCVA变化值与糖尿病性黄斑水肿病程、治疗前BCVA呈负相关(r=-0.422、-0.410,均为P<0.05);CMT变化值与糖尿病性黄斑水肿病程、治疗前CMT呈负相关(r=-0.430、-0.415,均为P<0.05)。结论 577 nm激光光凝联合玻璃体内注射康柏西普治疗糖尿病性黄斑水肿效果较好,其效果与患者基线BCVA、糖尿病性黄斑水肿病程有一定相关性。
Abstract:
Objective To investigate the effect of 577 nm laser photocoagulation combined with intravitreal injection of conbercept in the treatment of diabetic macular edema.Methods Totally 81 patients (81 eyes) with diabetic macular edema were selected in our hospital from January 2016 to March 2017,and the patients were divided into the observation group (43 patients 43 eyes) and the control group (38 patients 38 eyes) according to the patients’ final selection.The patients in the observation group were treated with 577 nm laser photocoagulation combined with intravitreal injection of conbercept,and the control group was treated with 577 nm laser photocoagulation only,and the best corrected visual acuity (BCVA) and central fovea of macula thickness (CMT) in the two groups before and after treatment were observed,and the correlation of BCVA and CMT changes in the observation group and initial factors were analyzed.Results The BCVA and CMT in the observation group and the control group improved with the prolongation of treatment time (all P<0.05).The BCVA at 1 months,3 months and 6 months after treatment in the observation group were 0.37±0.09,0.44±0.10 and 0.52±0.13,respectively,which were significantly higher than those in the control group (all P<0.05).The CMT at 1 months,3 months and 6 months after treatment in the observation group were (351.03±41.43)μm,(270.32±40.03)μm and (220.01±32.91)μm,respectively,which were significantly lower than that of the control group (all P<0.05).The change of BCVA was negatively correlated with the duration of diabetic macular edema and BCVA before treatment (r=-0.422 and -0.410,both P<0.05).The change of CMT were negatively correlated with the duration of diabetic macular edema and BCVA before treatment (r=-0.430 and -0.415,both P<0.05).Conclusion The effect of 577 nm laser photocoagulation combined with intravitreal injection of conbercept on diabetic macular edema is better,and the effect is related to the baseline visual acuity of the patients and duration of diabetic macular edema.

参考文献/References:

[1] ZHANG Z D,GUO S,SHUAI T J,PIAO T H.Effect of intravitreal injection of conbercept on diabetic diffuse macular edema[J].Rec Adv Ophthalmol,2018,38(1):69-72.
张召弟,郭晟,帅天姣,朴天华.玻璃体内注射康柏西普对弥漫性糖尿病性黄斑水肿的影响[J].眼科新进展,2018,38(1):69-72.
[2] HONG T T,LIU G F,GAO X X,FAN Y,WANG J.Short-term efficacy of intravitreal injection of Compaqip in diabetic macular edema and observation of changes in ellipsoidal integrity[J].Rec Adv Ophthalmol,2017,37(11):1053-1056.
洪婷婷,刘广峰,高新晓,范颖,汪军.糖尿病黄斑水肿玻璃体内注射康柏西普的短期疗效和椭圆体带完整性改变的观察[J].眼科新进展,2017,37(11):1053-1056.
[3] WANG C,LI D H,WEN Y Y.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Rec Adv Ophthalmol,2016,36(5):471-473.
王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471-473.
[4] WANG W L,HU X H.Effect of FFA and OCT in the diagnosis of diabetic macular edema[J].Int Eye Sci,2017,17(2):351-353.
[5] YAN Z Y,DONG M,YANG N,LI Y L,LI C Q,WANG L F.Clinical effect of intravesical injection of Compaqip in the treatment of diabetic retinopathy with macular edema[J].Shandong Med J,2017,57(37):57-59.
闫忠阳,冬敏,杨娜,李雅琳,李成泉,王莉菲.康柏西普玻璃体腔注射治疗糖尿病视网膜病变伴黄斑水肿的临床效果[J].山东医药,2017,57(37):57-59.
[6] CHENG Y,LIANG J H,LI X X.Intravitreal injection of conbercept for aggressive posterior retinopathy of prematurity[J].Chin J Ocul Fundus Dis,2017,33(2):144-147.
程湧,梁建宏,黎晓新.康柏西普玻璃体腔注射治疗急进性后极部早产儿视网膜病变的疗效观察[J].中华眼底病杂志,2017,33(2):144-147.
[7] BRESSLER N M,GLASSMAN A R,HUTTON D W.Controversies in using off-label intravitreous bevacizumab for patients with diabetic macular edema-reply[J].JAMA Ophthalmol,2017,135(3):291-292.
[8] XUE P C,YOU Z P,FU S H,PENG L,DONG L.Preoperative and intraoperative adjunctive intravitreal conbercept in 23G vitrectomy for proliferative diabetic retinopathy[J].Rec Adv Ophthalmol,2017,37(5):458-462.
薛鹏程,游志鹏,付书华,彭灵,董乐.23G玻璃体切割术前、术中辅助玻璃体内注射康柏西普治疗增生型糖尿病视网膜病变(PDR)的疗效分析[J].眼科新进展,2017,37(5):458-462.
[9] WYKOFF C C,ELMAN M J,REGILLO C D,DING B,LU N,STOILOV I.Predictors of diabetic macular edema treatment frequency with ranibizumab during the open-label extension of the RIDE and RISE trials[J].Ophthalmology,2016,123(8):1716-1721.
[10] WANG C,LI J,LYU G Y,GE R J,HUANG L.Correlation between the serum level of C-peptide and macroangiopathy in patients with type 2 diabetes mellitus[J].J Xinxiang Med Univ,2017,34(8):687-689.
王春,李娟,吕高友,葛荣靖,黄丽.血清C肽水平与 2型糖尿病患者大血管病变的相关性[J].新乡医学院学报,2017,34(8):687-689.
[11] WANG X,LI J,WANG P,YUAN K,YIN G,WAN B.Image guided radiation therapy boost in combination with high-dose-rate intracavitary brachytherapy for the treatment of cervical cancer[J].J Contemp Brachytherapy,2016,8(2):122-127.
[12] REN L,YANG W L,YAN J,WU Y Y,SANG Y M,ZHU C,et al.Scanning and analysis of the KATP channel mutations in 12 cases of infancy onset type 1 diabetes mellitus[J].Chin J Appl Clin Pediatr,2016,31(8):579-583.
任力,杨文利,闫洁,吴玉筠,桑艳梅,朱逞,等.婴儿期起病的1型糖尿病患儿12例ATP敏感性钾通道基因突变分析[J].中华实用儿科临床杂志,2016,31(8):579-583.
[13] LU Q,ZOU C,CAO H,ZHAO M,YU S,QIU Q,et al.Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma[J].Acta Ophthalmol,2016,94(4):414-415.
[14] YIN N,ZHAO S,ZHU H N.Conbercept pre-treatment combined with vitrectomy for proliferative diabetic retinopathy[J].Rec Adv Ophthalmol,2017,37(8):770-772.
尹妮,赵帅,朱红娜.康柏西普预处理联合玻璃体切割术治疗增生型糖尿病视网膜病变[J].眼科新进展,2017,37(8):770-772.

相似文献/References:

[1]张娣,张玲,杨静,等.玻璃体内注射康柏西普联合手术及全视网膜光凝治疗新生血管性青光眼[J].眼科新进展,2015,35(12):1170.[doi:10.13389/j.cnki.rao.2015.0320]
 ZHANG Di,ZHANG Ling,YANG Jing,et al.Intravitreal injection of conbercept combined with operation and panretinal photocoagulation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(4):1170.[doi:10.13389/j.cnki.rao.2015.0320]
[2]李娜,张杰,高荣玉,等.单次注射康柏西普治疗渗出型AMD患者RPE隆起面积与容积变化[J].眼科新进展,2016,36(2):172.[doi:10.13389/j.cnki.rao.2016.0047]
 LI Na,ZHANG Jie,GAO Rong-Yu,et al.Changes of retinal pigment epithelium uplift area and volume in exudative age-related macular degeneration after once injection of conbercept[J].Recent Advances in Ophthalmology,2016,36(4):172.[doi:10.13389/j.cnki.rao.2016.0047]
[3]王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471.[doi:10.13389/j.cnki.rao.2016.0126]
 WANG Chen,LI Dong-Hao,WEN Yi-Yi.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(4):471.[doi:10.13389/j.cnki.rao.2016.0126]
[4]王玮,徐玲娟,蔡苏博,等.角膜基质及结膜下单次注射康柏西普治疗角膜新生血管的疗效及安全性[J].眼科新进展,2016,36(8):725.[doi:10.13389/j.cnki.rao.2016.0192]
 WANG Wei,XU Lin-Juan,CAI Su-Bo,et al.Efficacy and safety of one dose intrastromal and subconjunctival conbercept injection for corneal neovascularization[J].Recent Advances in Ophthalmology,2016,36(4):725.[doi:10.13389/j.cnki.rao.2016.0192]
[5]史志洁,张金嵩,吕晓贝.玻璃体内注射康柏西普联合手术治疗伴玻璃体积血的新生血管性青光眼[J].眼科新进展,2016,36(8):751.[doi:10.13389/j.cnki.rao.2016.0200]
 SHI Zhi-Jie,ZHANG Jin-Song,LV Xiao-Bei.Intravitreal injection of conbercept and surgical treatment for neovascular glaucoma combined with vitreous hemorrhage[J].Recent Advances in Ophthalmology,2016,36(4):751.[doi:10.13389/j.cnki.rao.2016.0200]
[6]罗顺利,许泽广,梁春正.复合式小梁切除术联合康柏西普治疗新生血管性青光眼[J].眼科新进展,2016,36(11):1076.[doi:10.13389/j.cnki.rao.2016.0287]
 LUO Shun-Li,XU Ze-Guang,LIANG Chun-Zheng.Compound trabeculectomy with conbercept for neovascular glaucoma[J].Recent Advances in Ophthalmology,2016,36(4):1076.[doi:10.13389/j.cnki.rao.2016.0287]
[7]吴若欣,徐洁慧,温积全,等.玻璃体内注射康柏西普对渗出性老年性黄斑变性患者脉络膜厚度的影响[J].眼科新进展,2016,36(12):1172.[doi:10.13389/j.cnki.rao.2016.0312]
 WU Ruo-Xin,XU Jie-Hui,WEN Ji-Quan,et al.Effects of intravitreal conbercept injections on choroidal thickness in exudative age-related macular degeneration[J].Recent Advances in Ophthalmology,2016,36(4):1172.[doi:10.13389/j.cnki.rao.2016.0312]
[8]薛鹏程,游志鹏,付书华,等.23G玻璃体切割术前、术中辅助玻璃体内注射康柏西普治疗增生型糖尿病视网膜病变(PDR)的疗效分析[J].眼科新进展,2017,37(5):458.[doi:10.13389/j.cnki.rao.2017.0116]
 XUE Peng-Cheng,YOU Zhi-Peng,FU Shu-Hua,et al.Preoperative and intraoperative adjunctive intravitreal conbercept in 23G vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(4):458.[doi:10.13389/j.cnki.rao.2017.0116]
[9]朱磊,田晓燕,刘涛.玻璃体内注射康柏西普治疗湿性年龄相关性黄斑变性的临床观察[J].眼科新进展,2017,37(5):473.[doi:10.13389/j.cnki.rao.2017.0120]
 ZHU Lei,TIAN Xiao-Yan,LIU Tao.Intravitreal injection of conbercept for wet age-related macular degeneration[J].Recent Advances in Ophthalmology,2017,37(4):473.[doi:10.13389/j.cnki.rao.2017.0120]
[10]刘广峰,洪婷婷,苗森,等.玻璃体内注射康柏西普与黄斑区光凝治疗视网膜分支静脉阻塞继发非缺血性黄斑水肿的临床对照研究[J].眼科新进展,2017,37(7):658.[doi:10.13389/j.cnki.rao.2017.0167]
 LIU Guang-Feng,HONG Ting-Ting,MIAO Sen,et al.Comparison of intravitreal injection of conbercept and macular photocoagulation for non-ischemic macular edema secondary to branch retinal vein occlusion[J].Recent Advances in Ophthalmology,2017,37(4):658.[doi:10.13389/j.cnki.rao.2017.0167]

更新日期/Last Update: 2019-04-15